The Short Answer for AI Patent Eligibility Risk in 2026
Yes. As of September 24, 2026, U.S. patent applications involving artificial intelligence face higher eligibility risk than many conventional engineering applications, particularly when their claims recite model training, data analysis, prediction, optimization, or human-like reasoning without tying those operations to a defined technical improvement. The core problem is not that software is unpatentable. Computer-implemented inventions can qualify under 35 U.S.C. § 101 when they claim a practical technical process with a sufficiently concrete technological result, but examiners and courts increasingly ask whether the claim merely uses a computer to perform an abstract idea.
Also worth reading: What Are the USPTO Subject Matter Eligibility Guidelines for AI Inventions in 2026? · What Should an AI Patent Eligibility Checklist Cover in 2026? · How to use Rule 132 SMED evidence for AI patent eligibility after 2025 USPTO guidance?
The risk rose because the USPTO has been clarifying how patent eligibility should be applied to AI-related inventions, while court decisions continue to reject claims that amount to little more than mathematical rules, generic data processing, or an instruction to use a machine learning model. IPWatchdog reported a study showing higher rates of Section 101 invalidations for AI patents around an eligibility hearing, although the supplied research does not provide a defensible percentage that should be quoted as a general rejection rate. Reports from IAM Media, Law360, and JD Supra likewise point to increased attention to AI eligibility. The safe conclusion is heightened scrutiny, not a blanket ban on AI patents.
Business pressure is also increasing. McKinsey's 2026 technology outlook and reporting on AI data centers point to expanding infrastructure competition, while a Bloomberg Law report describes Micron Technology's Texas memory patent dispute and a reported $445 million outcome. Those events illustrate that valuable AI systems may depend on separately protectable memory, networking, accelerator, storage, and cooling technologies. Eligibility analysis must therefore be separated from ordinary infringement, validity, and freedom-to-operate questions.
Why AI Claims Are Especially Exposed
The governing U.S. framework combines § 101 eligibility doctrine with the written-description and enablement requirements of § 112. Under the Mayo and Alice framework, examiners may characterize broad claims as directed to an abstract idea, such as classifying information, predicting an outcome, or optimizing a parameter, and then ask whether the claim supplies an inventive concept beyond routine computer implementation. A reference to artificial intelligence or a neural network does not by itself answer that second question. Generic statements such as using a model to improve accuracy also often fail to distinguish a particular technical mechanism from a result-oriented wish.
AI applications are unusually vulnerable because their essential operations can be expressed at several abstraction levels. A claim may cover training a multilayer model, selecting features, generating a recommendation, controlling a physical device, or reducing data-center energy consumption. Only the last two examples necessarily reveal a specific technical improvement, and even those descriptions may be too broad if they do not explain how the improvement is achieved. The USPTO's 2026 eligibility guidance discussed in a Patent Eligibility Bulletin increases the need to identify those concrete implementation features before filing or amending an application.
The problem is compounded by overlap among statutes and claim types. A model-processing claim may be eligible under § 101 yet still be rejected for inadequate written description under § 112. An eligible training method may also be anticipated or rendered obvious by earlier work, while a technically narrow accelerator claim may be eligible but infringe a separate patent. Claims to human judgment, diagnosis, or creative activity can also raise eligibility concerns, although a medical device or diagnostic apparatus may be stronger than a claim directed only to an analytical result. Treating all of these issues as one Section 101 risk produces unreliable advice.
What Changed in 2026 and What Did Not
Several 2026 developments make AI patent eligibility a more immediate portfolio issue. The USPTO's renewed guidance signals closer examination of whether AI claims provide a technical improvement, and commentary from IPBC Global 2026 indicates that AI is forcing a reset of eligibility practice. A report by JD Supra also describes the USPTO moving to clarify patent eligibility for AI-related inventions. None of these developments creates a new statutory test, but they make examiner alignment and prosecution strategy more consequential.
At the same time, courts continue to narrow claims that describe AI functionality without a concrete technical implementation. Morgan Lewis summarized a Federal Circuit decision rejecting dental-related machine learning claims as too generic. The supplied research does not identify enough procedural detail to reproduce the full analysis, so the decision should be treated as a warning about claim specificity rather than proof that every medical AI claim is ineligible. The decisive lesson is that diagnosing a condition, calculating a probability, and displaying the result may remain abstract if the claim does not explain a particular improvement in the diagnostic apparatus or process.
Other reported developments should not be overstated. Stephen Thaler and DABUS are associated with an USPTO refusal based on the absence of a natural person as an inventor, not a broad holding that every AI-related invention fails Section 101. A 2026 Hogan Lovells Cadwalader discussion addresses AI-generated works and training-data disputes in China, illustrating that ownership, authorship, and training-data questions are moving internationally. Skadden's analysis likewise covers the changing relationship between AI and intellectual property. These issues matter for AI patent strategy, but copyright authorship, inventorship, data rights, and patent eligibility should not be collapsed into a single rule.
Technical Features That Can Reduce Eligibility Risk
A stronger claim usually identifies a specific architecture, data flow, control mechanism, or measurable technical effect. For example, an application might define how a particular accelerator arrangement reduces memory movement during inference, rather than claiming the prediction itself. It might explain a sensor-and-computation sequence that improves an industrial control loop, or a distributed system that reduces network latency under defined workloads. The important feature is not the presence of a technical word such as efficient or real time; the application should explain what is different and how the difference is achieved.
Claims should also distinguish input from the resulting technical operation. Receiving generic data, applying a trained model, and outputting a recommendation recreates a common abstract-idea pattern. By contrast, a claim that specifies a transformed data representation, a particular control signal, a changed memory state, or a defined interaction with physical equipment may present a stronger eligibility case. The USPTO and courts do not require every eligible claim to contain hardware, but software claims that solve a technical problem through a specific software architecture can still qualify.
| Claim strategy | Likely eligibility treatment | Main strength | Residual risk |
|---|---|---|---|
| Generic model output or prediction | Higher § 101 risk | Covers a broad commercial use | May be treated as an abstract result or mental process |
| Specific model architecture and training mechanism | Lower risk if truly novel and concrete | Defines how computation is performed | May still encounter § 112 or prior-art objections |
| AI controlling a described physical system | Potentially stronger | Ties computation to a technical operation | Generic or result-based limitations can undermine the claim |
| Data-center hardware, cooling, memory, or networking claim | Often stronger than a generic AI method | Describes a physical or systems improvement | Can be limited by separate hardware patents |
| Inventor named as a human who conceived the claimed subject matter | Required for U.S. practice | Supports clear ownership and prosecution | Does not itself prove eligibility or nonobviousness |
| Filing based on an assertion that a system invents | Not an acceptable U.S. strategy | None in the patent system | Inventorship remains human-centered |
Start with a claim-focused technical record rather than a market description. Document the original technical problem, the specific system changes, measurable performance gains, and why a person skilled in the art could reproduce the invention. Identify the smallest concrete mechanism that produces the technical result, and separate optional AI components from the core disclosed process. This exercise often reveals that the commercially valuable innovation lies in data preparation, memory management, control logic, or hardware coordination rather than the broad objective of using AI.
Then conduct separate searches for § 101 risk, § 112 support, and prior art. A search that finds many generic machine-learning patents is not equivalent to a § 101 analysis, while a persuasive eligibility argument cannot repair an abstract claim that is anticipated or obvious. Counsel should map each proposed independent claim to specific specification passages, laboratory data, diagrams, and implementation details. If the only support is a high-level statement that the system uses AI to improve performance, narrowing the claim may expose an underlying § 112 problem rather than solve it.
Inventorship must be handled with equal care. Every named inventor must be a natural person who contributed to the conception of the claimed invention, while routine coding, funding, and management do not necessarily establish inventorship by themselves. Assign the application to the correct business entity and confirm that employment, contractor, and joint-development agreements preserve the expected ownership chain. The DABUS dispute demonstrates why an AI system cannot simply be placed in the inventor field, but it does not justify naming no human inventor when a human conceived the claimed subject matter.
Comparing Patents, Trade Secrets, and Alternatives
Not every AI innovation should be filed as a U.S. patent. A patent can provide a published, enforceable right that discourages competitors and supports licensing, but it requires public disclosure, costs, and a presumption of validity that competitors may challenge. A trade secret avoids public disclosure and can remain protected indefinitely if the company uses reasonable secrecy measures. That advantage is especially relevant for training recipes, optimization heuristics, and rapidly changing operational data, although trade-secret protection is difficult when products expose outputs or when employees and vendors can reveal the underlying method.
| Protection route | Disclosure | Potential duration | Enforcement burden | Better fit for |
|---|---|---|---|---|
| U.S. utility patent | Public and enabling | Generally 20 years from the earliest qualifying nonprovisional filing date | Litigation can be expensive and validity can be challenged | Concrete technical mechanisms with a long product cycle |
| Provisional application | Not published as such; mature content is usually filed later | It does not mature into a patent by itself | Informal and subject to later formal filing requirements | Preserving a filing date while technical details develop |
| Trade secret | No required public disclosure | Potentially unlimited while secrecy is maintained | Proving misappropriation and controlling access can be difficult | Fast-changing models, data pipelines, and operational know-how |
| Copyright | Protects original expression in qualifying works | Life plus 70 years for U.S. works authored on or after January 1, 1978 | Does not protect the underlying AI method as such | Code, documentation, interface art, and qualifying text |
| Contractual controls | Depends on the agreement | Contract term plus applicable trade-secret law | Requires enforceable confidentiality and access terms | Vendor data, joint development, and employee know-how |
Common Mistakes That Increase AI Patent Risk
The most common mistake is treating the patent system as protection for a business objective. A statement that an invention improves productivity, personalization, or decision-making tells a customer what value is desired but may not tell an examiner what technological mechanism is claimed. Another error is adding labels such as neural, adaptive, or real time without defining the relevant data structures, operations, or technical constraints. These words consume claim space while adding little to eligibility.
Applicants also make the mistake of assuming that hardware automatically cures an abstract method. A generic server or processor recited only as a place to execute instructions may not supply an inventive concept. The opposite mistake occurs when important technical interactions are omitted from the claims because the application treats them as implementation details. Disclosure should support multiple claim positions, while the claims themselves must identify the specific improvement being asserted.
Cost pressure can create a third error: filing dozens of applications built from nearly identical AI claim language without a prior-art or eligibility review. Repetition does not remove § 101 exposure, and narrowly focused claims can still carry commercial value. AI portfolio review should therefore consider claim scope, expected product life, ownership, and the cost of maintaining invalid or irrelevant rights. It should not rely on the number of applications as a measure of protection strength.
When to Act and What It May Cost
An applicant should act before a critical public disclosure, conference submission, sales demonstration, or vendor publication because many U.S. filing routes contain limited grace periods with different conditions. A company preparing for diligence, a funding round, a product launch, or a cross-license negotiation also benefits from early review. If an application is already pending, the relevant deadline may be the filing date rather than the eventual examination date, and amendments made after a first rejection may be constrained by the original disclosure.
The USPTO charges official fees, but the largest planning cost is usually professional search and drafting work. As a nonbinding 2026 market-planning range, a focused prior-art and patentability review may cost roughly $5,000 to $30,000, while a more extensive landscape study can exceed $30,000. Complex U.S. utility prosecution is often budgeted in the tens of thousands of dollars over several years, with costs varying by entity status, claim count, amendment complexity, and the depth of technical input required. Official small-entity and micro-entity fees should be confirmed on the USPTO's current fee schedule rather than inferred from older articles.
Litigation can change the economics entirely. Patent litigation may involve millions of dollars in fees, discovery, expert work, and settlement pressure, so eligibility screening is usually economical before a large filing program. That screening is not a promise of validity or nonobviousness. It is a method for deciding whether a disclosed technical mechanism deserves the expense of patent prosecution and whether trade-secret or contractual protection would be more appropriate for other parts of the AI stack.
The Defensive and Portfolio-Level View
A mature response to AI patent eligibility risk begins with an asset inventory, not a universal filing policy. Companies should map models, software, datasets, chips, memory systems, cooling arrangements, control software, and deployment methods to their current patents, applications, trade secrets, contracts, and open-source obligations. This map helps identify which assets are exposed to Alice-style eligibility objections and which are exposed to ordinary infringement claims involving hardware or data-center infrastructure.
The reported $445 million Micron memory dispute shows why that separation matters. An AI company may believe it needs patent protection for its model, but the immediate dispute may concern a separate memory technology used to run the system. Data-center expansion can also increase exposure to claims covering power management, thermal control, networking, and specialized processors. Freedom-to-operate work for those components should be scheduled alongside prosecution, rather than waiting until a product is close to deployment.
Ultimately, U.S. AI patent risk in 2026 is manageable but not low. The strongest applications will disclose a real technical advance, name the proper human inventors, claim that advance with appropriate specificity, and preserve alternatives supported by the specification. A company that relies only on the commercial promise of AI, or that assumes every algorithm is abstract, will make poor decisions in opposite directions. The defensible position is narrower: the USPTO and courts are not prohibiting AI patents, yet eligibility scrutiny has increased enough to make claim design, human inventorship, and layered portfolio planning business-critical.
This is general legal information, not advice for a specific application, and eligibility outcomes depend on the claim language, specification, prior art, examination record, and jurisdiction.